William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...

Fintel reports that on March 31, 2026, William Blair upgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Market Perform to Outperform. Analyst Price Forecast Suggests 4.45% Upside As of March ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read ...

A team of cancer genomics scientists from The University of Manchester and The Institute of Cancer Research, London, ...

Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...

When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that. Genomics is a key part of the health system’s ...

For public health, cloud-native scientific computing delivers the security and simplicity needed for the path from ...

When producers look to their veterinarians for genomics advice, many may not feel fully confident leading that discussion.

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how ...

Madras Diabetes Research Foundation and Premas Life Sciences collaborate to enhance genomics research for improved diabetes ...